August 27th, 2008

You are currently browsing the articles from acne control for skin written on August 27th, 2008.

Appeals court tosses lawsuit over anti-acne drug (Atlanta Journal-Constitution)

A federal appeals court has upheld the dismissal of a lawsuit claiming that the anti-acne drug Accutane causes a chronic bowel disorder. The consolidated lawsuit by nine plaintiffs accused New Jersey-based drug manufacturer Hoffman-La Roche Inc. of downplaying a link between Accutane and inflammatory bowel disease, which afflicts about 1.4 million people in the U.S. and Canada. U.S. District …

Written by admin on August 27th, 2008 with no comments.
Read more articles on acne control for skin.

‘Free’ acne product prompts rash of complaints (Vancouver Sun)

B.C. I Consumers say they are continuing to pay for their acne scar treatment even if they opt out of the program.

Written by admin on August 27th, 2008 with no comments.
Read more articles on acne control for skin.

Appeals court nixes lawsuit over anti-acne drug (Miami Herald)

A federal appeals court has upheld the dismissal of a lawsuit claiming that the anti-acne drug Accutane causes a chronic bowel disorder.

Written by admin on August 27th, 2008 with no comments.
Read more articles on acne control for skin.

The psychosocial price of acne: $275 (The Globe and Mail)

How much would teens pay to erase acne completely? On average, $275, according to a new study

Written by admin on August 27th, 2008 with no comments.
Read more articles on acne control for skin.

New Product Brings Benefits of Clinical Phototherapy Directly to Millions of Acne Sufferers (Centre Daily Times)

Portland, Ore.-based Oregon Aesthetic Technologies (OAT) today announced the availability of ANSR: Acne Care, a next-generation acne treatment featuring clinically proven phototherapy and a powerful set of topical ingredients to fight acne and heal the skin.

Written by admin on August 27th, 2008 with no comments.
Read more articles on acne control for skin.

« Older articles

No newer articles